Kuros Biosciences AG – SIX:KURN.SW
Kuros Biosciences AG stock price today
Kuros Biosciences AG stock price monthly change
Kuros Biosciences AG stock price quarterly change
Kuros Biosciences AG stock price yearly change
Kuros Biosciences AG key metrics
Market Cap | 764.12M |
Enterprise value | N/A |
P/E | -2.83 |
EV/Sales | -21.79 |
EV/EBITDA | 0.75 |
Price/Sales | 0.35 |
Price/Book | N/A |
PEG ratio | 0.03 |
EPS | -0.57 |
Revenue | 50.34M |
EBITDA | -9.43M |
Income | -20.59M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -3082.5% |
Oper. margin | -2326.6% |
Gross margin | 100% |
EBIT margin | -2326.6% |
EBITDA margin | -18.74% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeKuros Biosciences AG stock price history
Kuros Biosciences AG stock forecast
Kuros Biosciences AG financial statements
| Mar 2023 | 6.43M | -2.52M | -39.27% |
|---|---|---|---|
| Jun 2023 | 12.86M | -5.05M | -39.27% |
| Sep 2023 | 10.34M | -4.33M | -41.91% |
| Dec 2023 | 20.69M | -8.67M | -41.91% |
| 2025 | 107.8M | 5.48M | 5.09% |
|---|---|---|---|
| 2026 | 140.3M | 11.70M | 8.34% |
| 2027 | 150M | 0 | |
| 2028 | 172.1M | 0 |
Analysts Price target
Financials & Ratios estimates
| Mar 2023 | 78256000 | 14.29M | 18.27% |
|---|---|---|---|
| Jun 2023 | 78256000 | 14.29M | 18.27% |
| Sep 2023 | 71464000 | 14.75M | 20.64% |
| Dec 2023 | 75906000 | 19.19M | 25.29% |
| Mar 2023 | -3.37M | -46K | -154.5K |
|---|---|---|---|
| Jun 2023 | -6.74M | -92K | -309K |
| Sep 2023 | -1.04M | -117K | 69K |
| Dec 2023 | -2.09M | -234K | 138K |
Kuros Biosciences AG alternative data
| Aug 2023 | 66 |
|---|---|
| Sep 2023 | 73 |
| Oct 2023 | 73 |
| Nov 2023 | 73 |
| Dec 2023 | 73 |
| Jan 2024 | 73 |
| Feb 2024 | 73 |
| Mar 2024 | 80 |
| Apr 2024 | 80 |
| May 2024 | 80 |
| Jun 2024 | 80 |
| Jul 2024 | 80 |
Kuros Biosciences AG other data
| Patent |
|---|
Application Filling date: 13 Apr 2021 Issue date: 24 Mar 2022 |
Application Filling date: 16 Oct 2019 Issue date: 16 Jul 2020 |
| Insider | Compensation |
|---|---|
Mr. Michael Grau M.B.A., MBA (1962) Chief Financial Officer | $417,500 |
Prof. Joost D. de Bruijn B.S., Ph.D., B.Sc. Ph.D. (1966) Chief Executive Officer & Director | $402,000 |
-
What's the price of Kuros Biosciences AG stock today?
One share of Kuros Biosciences AG stock can currently be purchased for approximately $1.98.
-
When is Kuros Biosciences AG's next earnings date?
Unfortunately, Kuros Biosciences AG's (KURN.SW) next earnings date is currently unknown.
-
Does Kuros Biosciences AG pay dividends?
No, Kuros Biosciences AG does not pay dividends.
-
How much money does Kuros Biosciences AG make?
Kuros Biosciences AG has a market capitalization of 764.12M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 86.61% to 33.56M US dollars.
-
What is Kuros Biosciences AG's stock symbol?
Kuros Biosciences AG is traded on the SIX under the ticker symbol "KURN.SW".
-
What is Kuros Biosciences AG's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Kuros Biosciences AG?
Shares of Kuros Biosciences AG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Kuros Biosciences AG's key executives?
Kuros Biosciences AG's management team includes the following people:
- Mr. Michael Grau M.B.A., MBA Chief Financial Officer(age: 63, pay: $417,500)
- Prof. Joost D. de Bruijn B.S., Ph.D., B.Sc. Ph.D. Chief Executive Officer & Director(age: 59, pay: $402,000)
-
How many employees does Kuros Biosciences AG have?
As Jul 2024, Kuros Biosciences AG employs 80 workers.
-
When Kuros Biosciences AG went public?
Kuros Biosciences AG is publicly traded company for more then 22 years since IPO on 29 Oct 2002.
-
What is Kuros Biosciences AG's official website?
The official website for Kuros Biosciences AG is kuros.ch.
-
How can i contact Kuros Biosciences AG?
Kuros Biosciences AG can be reached via phone at +41 44 733 47 47.
Kuros Biosciences AG company profile:
Kuros Biosciences AG
kuros.chSIX
106
Biotechnology
Healthcare
Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development of biopharmaceutical products for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company's orthobiologics pipeline products include MagnetOs Granules and MagnetOs Putty in EU and US for the treatment of orthopedics, spinal, and dental problems. Its fibrin/PTH orthobiologics pipeline products comprise KUR-111, which has completed Phase 2b clinical trial for the treatment of tibial plateau fractures; and KUR-113, which completed Phase 2b clinical trial for the treatment of tibial shaft fractures, as well as is in the Phase II trial for the treatment of spinal interbody fusion. The company's sealants pipeline products include Neuroseal EU and US, synthetic tissue sealant for the prevention of cerebrospinal fluid leakage following cranial or spinal surgery. It has collaboration with Checkmate Pharmaceuticals LLC for the development of CYT003 for the treatment of oncology. The company is headquartered in Schlieren, Switzerland.
Schlieren, 8952
:
ISIN: CH0325814116
CUSIP: H4769G117
